Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Glioblastoma 5Recurrence 4Head and Neck Neoplasms 3Diffuse Intrinsic Pontine Glioma 3Glioma 2Brain Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Recurrence of Head and Cancer in Irraiated Area 1Pelvic Neoplasms 1Pancreatic Neoplasms 1Nasopharyngeal Neoplasms 1Nasopharyngeal Diseases 1Nasopharyngeal Carcinoma 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1Breast Cancer Recurrent 1Brain Stem Neoplasms 1

Interventions

Gemcitabine 679130-nm albumin-bound paclitaxel 198Fluorouracil 186Oxaliplatin 175Albumin-Bound Paclitaxel 151Capecitabine 137Leucovorin 131Irinotecan 113Radiotherapy 95Taxes 83pembrolizumab 80Cisplatin 72Erlotinib Hydrochloride 69Radiosurgery 67Nivolumab 56Bevacizumab 54Drug Therapy 52Cyclophosphamide 49Magnetic Resonance Spectroscopy 46folfirinox 42Docetaxel 41Cetuximab 40Specimen Handling 37irinotecan sucrosofate 36S 1 (combination) 36Biopsy 31Radiation 29Paclitaxel 29Ipilimumab 27durvalumab 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pancreatic Neoplasms × Re-Irradiation × Clear all
NCT02745847 2023-05-25

Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic Cancer

Changhai Hospital

Phase NA Unknown
30 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡